Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
by on Tuesday, June 5th, 2012 | No Comments
Condition: Cytomegalovirus Infections
Intervention: Drug: Maribavir
Sponsors: ViroPharma; ViroPharma
Not yet recruiting – verified June 2012
Continued here: Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients